NRXP Financial Statements

Balance sheet, income statement, cash flow, and dividends for Nrx Pharmaceuticals Inc (NRXP).


$38.60M Market Cap.

As of 04/01/2024 5:00 PM ET (MRY) • Disclaimer

NRXP Market Cap. (MRY)


NRXP Shares Outstanding (MRY)


NRXP Assets (MRY)


Total Assets

$7.32M

Total Liabilities

$19.05M

Total Investments

$0

NRXP Income (MRY)


Revenue

$0

Net Income

-$30.15M

Operating Expense

$27.84M

NRXP Cash Flow (MRY)


CF Operations

-$21.66M

CF Investing

-$3.00K

CF Financing

$6.20M

NRXP Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

0%

0%

-

2019

$0

0%

-

0%

-

NRXP Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

$7,315,000 (-71.66%)

$25,816,000 (-21.12%)

$32,729,000 (1012.79%)

$2,941,169 (198.31%)

Assets Current

$6,884,000 (-73.31%)

$25,795,000 (-21.15%)

$32,714,000 (1016.42%)

$2,930,255 (200.54%)

Assets Non-Current

$431,000 (1952.38%)

$21,000 (40.00%)

$15,000 (37.44%)

$10,914 (-0.15%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

-$11,733,000 (-258.36%)

$7,409,000 (-64.39%)

$20,806,000 (147.53%)

-$43,770,883 (-802.32%)

Property Plant & Equipment Net

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cash & Equivalents

$4,595,000 (-77.09%)

$20,054,000 (-27.35%)

$27,605,000 (1385.33%)

$1,858,513 (111.82%)

Accumulated Other Comprehensive Income

-$3,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$831,390 (0%)

Trade & Non-Trade Payables

$4,632,000 (123.12%)

$2,076,000 (-43.69%)

$3,687,000 (16.92%)

$3,153,310 (52.08%)

Accumulated Retained Earnings (Deficit)

-$253,147,000 (-13.52%)

-$222,997,000 (-21.69%)

-$183,243,000 (-103.20%)

-$90,179,720 (-134.83%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$9,161,000 (-12.96%)

$10,525,000 (1931.85%)

$518,000 (-34.98%)

$796,688 (-78.73%)

Debt Current

$9,161,000 (18.93%)

$7,703,000 (1387.07%)

$518,000 (108.15%)

$248,861 (-12.51%)

Debt Non-Current

$0 (0%)

$2,822,000 (0%)

$0 (0%)

$547,827 (-84.18%)

Total Liabilities

$19,048,000 (3.48%)

$18,407,000 (54.38%)

$11,923,000 (-74.48%)

$46,712,052 (700.29%)

Liabilities Current

$19,048,000 (22.22%)

$15,585,000 (30.71%)

$11,923,000 (-74.17%)

$46,164,225 (1843.69%)

Liabilities Non-Current

$0 (0%)

$2,822,000 (0%)

$0 (0%)

$547,827 (-84.18%)

NRXP Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$14,216,000 (-47.94%)

$27,308,000 (-63.56%)

$74,944,000 (555.33%)

$11,436,000 (313.21%)

Research & Development Expense

$13,371,000 (-21.47%)

$17,027,000 (-15.95%)

$20,257,000 (90.65%)

$10,625,000 (203.95%)

Operating Expenses

$27,837,000 (-37.21%)

$44,335,000 (-61.71%)

$115,796,000 (125.34%)

$51,387,000 (720.45%)

Interest Expense

$120,000 (0%)

$0 (0%)

$18,000 (-67.86%)

$56,000 (-81.52%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$30,150,000 (24.16%)

-$39,754,000 (57.28%)

-$93,063,000 (-79.74%)

-$51,777,000 (-669.44%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$30,150,000 (24.16%)

-$39,754,000 (57.28%)

-$93,063,000 (-79.74%)

-$51,777,000 (-669.44%)

Preferred Dividends Income Statement Impact

$9,000 (0%)

$0 (0%)

$255,822,000 (0%)

$0 (0%)

Net Income Common Stock

-$30,159,000 (24.14%)

-$39,754,000 (88.61%)

-$348,885,000 (-573.82%)

-$51,777,000 (-669.44%)

Weighted Average Shares

$75,761,763 (15.20%)

$65,766,786 (40.17%)

$46,917,701 (36.90%)

$34,270,955 (220.58%)

Weighted Average Shares Diluted

$75,761,763 (15.20%)

$65,766,786 (40.17%)

$46,917,701 (36.90%)

$34,270,955 (220.58%)

Earning Before Interest & Taxes (EBIT)

-$30,030,000 (24.46%)

-$39,754,000 (57.27%)

-$93,045,000 (-79.90%)

-$51,721,000 (-704.86%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$27,837,000 (37.21%)

-$44,335,000 (61.71%)

-$115,796,000 (-125.34%)

-$51,387,000 (-720.45%)

NRXP Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

-$3,000 (70.00%)

-$10,000 (-42.86%)

-$7,000 (-250.00%)

-$2,000 (43.69%)

Net Cash Flow from Financing

$6,201,000 (-80.75%)

$32,214,000 (-49.23%)

$63,456,000 (1853.09%)

$3,249,000 (-44.00%)

Net Cash Flow from Operations

-$21,657,000 (45.52%)

-$39,755,000 (-5.44%)

-$37,703,000 (-1564.59%)

-$2,265,000 (59.13%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$15,459,000 (-104.73%)

-$7,551,000 (-129.33%)

$25,746,000 (2521.79%)

$982,000 (283.41%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$3,000 (70.00%)

-$10,000 (-42.86%)

-$7,000 (-250.00%)

-$2,000 (43.69%)

Issuance (Repayment) of Debt Securities

-$3,092,000 (-132.54%)

$9,502,000 (844.67%)

-$1,276,000 (-305.81%)

$620,000 (0%)

Issuance (Purchase) of Equity Shares

$8,122,000 (-64.24%)

$22,712,000 (-64.91%)

$64,732,000 (2409.97%)

$2,579,000 (-55.55%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$387,000 (-89.33%)

$3,628,000 (-94.11%)

$61,622,000 (8341.37%)

$730,000 (-21.83%)

Depreciation Amortization & Accretion

$5,000 (25.00%)

$4,000 (100.00%)

$2,000 (0.00%)

$2,000 (132.83%)

NRXP Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

573.30% (392.80%)

-195.80% (-100.57%)

34059.90% (5354.82%)

624.40% (335.44%)

Return on Average Assets (ROAA)

-194.50% (-54.98%)

-125.50% (90.10%)

-1267.50% (-31.22%)

-965.90% (-5789.63%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

548.40% (-72.57%)

1999.20% (403.96%)

396.70% (-61.82%)

1039.00% (6890.85%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.15 (37.84%)

-1.85 (23.36%)

-2.41 (85.06%)

-16.16 (3.96%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

-3.29 (-132.46%)

10.13 (-24.99%)

13.51 (1001.33%)

-1.5 (88.70%)

Debt to Equity Ratio (D/E)

-1.62 (-165.34%)

2.48 (333.51%)

0.57 (153.70%)

-1.07 (11.31%)

Earnings Per Share (EPS)

-0.4 (33.33%)

-0.6 (69.70%)

-1.98 (-31.13%)

-1.51 (-139.68%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.29 (52.73%)

-0.6 (24.75%)

-0.8 (-1118.18%)

-0.07 (87.28%)

Book Value Per Share (BVPS)

-0.15 (-237.17%)

0.11 (-74.49%)

0.44 (134.69%)

-1.28 (-181.28%)

Tangible Assets Book Value Per Share (TABVPS)

0.1 (-75.32%)

0.39 (-43.70%)

0.7 (711.63%)

0.09 (-6.52%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0.00%)

-1 (66.67%)

-3 (-200.00%)

-1 (90.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.32 (7.34%)

-1.43 (45.19%)

-2.61 (-98.40%)

-1.31 (87.18%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

0.36 (-78.19%)

1.66 (-39.69%)

2.74 (4255.56%)

0.06 (-84.67%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$21,660,000 (45.53%)

-$39,765,000 (-5.45%)

-$37,710,000 (-1563.43%)

-$2,267,000 (59.12%)

Enterprise Value (EV)

$39,769,995 (-30.02%)

$56,832,859 (-76.59%)

$242,744,906 (256.95%)

$68,004,453 (3.15%)

Earnings Before Tax (EBT)

-$30,150,000 (24.16%)

-$39,754,000 (57.28%)

-$93,063,000 (-79.74%)

-$51,777,000 (-669.44%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$30,025,000 (24.47%)

-$39,750,000 (57.28%)

-$93,043,000 (-79.90%)

-$51,719,000 (-704.93%)

Invested Capital

-$7,167,000 (-1120.94%)

$702,000 (111.18%)

-$6,281,000 (85.82%)

-$44,284,881 (-3092.87%)

Working Capital

-$12,164,000 (-219.14%)

$10,210,000 (-50.89%)

$20,791,000 (148.09%)

-$43,233,970 (-2987.98%)

Tangible Asset Value

$7,315,000 (-71.66%)

$25,816,000 (-21.12%)

$32,729,000 (1012.79%)

$2,941,169 (198.31%)

Market Capitalization

$38,602,995 (-48.59%)

$75,081,859 (-73.29%)

$281,113,416 (328.57%)

$65,593,105 (1.96%)

Average Equity

-$5,260,500 (-125.90%)

$20,308,000 (2082.57%)

-$1,024,326 (87.65%)

-$8,291,921 (-426.81%)

Average Assets

$15,503,500 (-51.04%)

$31,668,500 (15.06%)

$27,524,550 (413.47%)

$5,360,500 (-86.96%)

Invested Capital Average

-$5,475,750 (-175.37%)

-$1,988,500 (91.52%)

-$23,455,276 (-371.18%)

-$4,978,020 (-111.85%)

Shares

83,919,554 (24.07%)

67,641,314 (15.02%)

58,810,338 (2087.69%)

2,688,242 (-55.70%)